Fourth Quarter 2025 Earnings Presentation March 2026 Important notice Cautionary Note Regarding Forward-Looking Statements and Projections. Certain statements in this presentation may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, each as amended. Forward-looking statements provide current expectations of future events and include any statemen ...

4 th Quarter 2025 Earnings Presentation Mar 2026 Disclaimer Agenda 4 th Quarter 2025 Achievements and Growth Strategies Recent Developments 4 th Quarter 2025 Financial Performance Overview 01 02 03 The information in this presentation is provided to you by Yalla Group Limited (the "Company") solely for informational purposes and is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any security or instrument of the Company, or to participate in any investment activity or trading stra ...

Financial Data and Key Metrics Changes - The overall net operating income (NOI) for the fourth quarter of 2025 was $10.9 million, an increase from $7 million in the prior quarter [10] - Core Funds from Operations (FFO) was negative $5.9 million, compared to negative $7 million in the prior year [24] - The company reported a negative FFO of $7.1 million, or negative $4.49 per diluted share, an improvement from negative $8.7 million, or negative $23.21 per diluted share in the prior year [23] Business Line Data and Key Metrics Changes - Office segment NOI for Q4 2025 was $6.4 million, up from $5.2 million during Q4 2024, driven by increased occupancy and rental rates in properties located in Austin and Beverly Hills [19][20] - Hotel segment NOI for Q4 2025 was $2.1 million, consistent with the prior year [21] - Multifamily segment NOI decreased to a loss of $870,000 during Q4 2025, compared to income of $855,000 in the prior year, primarily due to unrealized losses on investments [21] Market Data and Key Metrics Changes - In Oakland, the vacancy rate declined to 8% from a high of 18% in 2001, with rent growth turning positive in 2025 after three years of declines [16] - The office segment occupancy rate reached 88.5% at the end of 2025, a 190 basis point increase from the third quarter and a 680 basis point improvement year-over-year [8][17] Company Strategy and Development Direction - The company is focusing on premier multifamily assets, strengthening its balance sheet, and improving liquidity [4] - The company completed the sale of its lending division for approximately $44.9 million, generating about $31.2 million in net cash proceeds [6][7] - The company plans to redeem approximately 2 million shares of Series A preferred stock, which is expected to improve annual FFO by approximately $16 million [5] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about improving cash flow in 2026, supported by rising net operating income across all segments [8] - The company anticipates lower interest expenses due to a potentially more favorable rate environment and plans to refinance the hotel following renovations [9] - Management noted that the company does not currently intend to initiate additional preferred stock redemptions but will evaluate requests as they arise [6] Other Important Information - The company has completed nine refinancings and fully retired its $169 million recourse credit facility [12] - The company is working on the extension of two more assets expected to be completed in Q2 2026 [12] Q&A Session Summary Question: What are the expectations for future cash flow improvements? - Management indicated that they see opportunities to improve cash flow in 2026, supported by several key drivers across the portfolio [8] Question: How is the company addressing its preferred stock redemptions? - Management stated that they do not currently intend to initiate additional preferred stock redemptions but will evaluate requests as they come in [6] Question: What is the status of the hotel renovations? - Management confirmed that the renovations at the Sheraton Grand Sacramento have been substantially completed and are expected to positively impact profitability [18]

Financial Data and Key Metrics Changes - In Q4 2025, the company achieved 10% revenue growth and 9% gross profit growth on a normalized year-over-year basis, excluding political media contributions from 2024 [5][14] - Adjusted EBITDA margins were 41%, and free cash flow conversion was 43% [5][15] - Q4 revenue was $78.6 million, and gross profit was $58.3 million, with gross profit margins at approximately 74.2% [13][14] Business Line Data and Key Metrics Changes - In the consumer payment segment, Q4 revenue increased by 8% and gross profit increased by 6% year-over-year [5][14] - The business payments segment saw normalized revenue increase by 41% and gross profit increase by 73% year-over-year [7][14] - The supplier network in the business payments segment grew to 602,000 suppliers, a 65% increase year-over-year [8] Market Data and Key Metrics Changes - The company noted stable trends in the auto and personal loans markets, with no significant changes reported in healthcare or mortgage sectors [26][27] - The political media contributions are expected to positively impact revenue by $8 million to $10 million in 2026, contributing approximately 3 percentage points to reported growth year-over-year [20] Company Strategy and Development Direction - The company is focused on improving operations, go-to-market strategies, and overall organizational leadership to support growth in 2026 [4][10] - Strategic changes in 2025 included executive changes, process streamlining, and investments in automation and AI to enhance operational efficiency [10][11] - The company plans to allocate capital towards organic growth opportunities, strategic M&A, and partnerships to boost long-term growth [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving double-digit reported revenue growth in 2026, driven by existing client growth and new client ramp-up [18][22] - The first quarter of 2026 is expected to show lower year-over-year growth due to delayed client implementations, with a return to strong double-digit normalized growth anticipated in the second half of the year [20][22] - The company is positioned to leverage AI capabilities to enhance productivity and streamline client onboarding processes [11][12] Other Important Information - The company ended 2025 with approximately $116 million in cash and a pro forma total liquidity of about $219 million [16][17] - The company has $23 million remaining under its existing share repurchase program for 2026 [21] Q&A Session Summary Question: Insights on major end markets like auto, personal loans, healthcare, and mortgage - Management noted stable trends in auto and personal loans, with no significant changes in healthcare or mortgage markets [26][27] Question: Any upcoming customer renewals in 2026 - Management indicated no major renewals outside of standard auto-renewals that are already embedded in guidance [28] Question: Impact of tax refunds on volumes and repayment activity - Management observed a seasonal uplift in payment volume during tax refund season, consistent with previous years [32][33] Question: Contribution of float income to growth and margins - Float income from customer deposits in the B2B business contributed positively to fourth-quarter results, with stable expectations for 2026 [34][35] Question: Update on M&A pipeline and focus areas - Management confirmed a healthy M&A pipeline with opportunities in both consumer and business payments, focusing on partnerships that complement existing business units [39] Question: Growth expectations for the business payment segment - Management anticipates high teens growth for the business payments segment, influenced by the political year and expected contributions from political media [52][53]

Financial Data and Key Metrics Changes - The company's overall net operating income (NOI) for Q4 2025 was $10.9 million, an increase from $7 million in the prior quarter [10] - Core Funds from Operations (FFO) was negative $5.9 million, compared to negative $7 million in the prior year [24] - The overall FFO was negative $7.1 million, or negative $4.49 per diluted share, an improvement from negative $8.7 million, or negative $23.21 per diluted share in the prior year [23][24] Business Line Data and Key Metrics Changes - Office segment NOI increased to $6.4 million in Q4 2025 from $5.2 million in Q4 2024, driven by higher occupancy and rental rates [20][21] - Hotel segment NOI for Q4 2025 was $2.1 million, consistent with the prior year [22] - Multifamily segment NOI decreased to a loss of $870,000 in Q4 2025, compared to income of $855,000 in the prior year, primarily due to unrealized losses on investments [22] Market Data and Key Metrics Changes - In Oakland, multifamily occupancy improved to 88.4% at year-end 2025, a 370 basis point increase from the end of Q3 2025 [17] - The office segment occupancy reached 88.5% at the end of 2025, a 190 basis point improvement from Q3 2025 and a 680 basis point improvement year-over-year [18] - Rent growth in downtown San Francisco was 7.6% in 2025, the highest in over 25 years, with the vacancy rate declining to its lowest levels in 15 years [16] Company Strategy and Development Direction - The company is focusing on premier multifamily assets, strengthening its balance sheet, and improving liquidity [4] - Actions taken since September 2024 include financing on nine assets and the sale of the lending division, which generated approximately $31.2 million in net cash proceeds [5][6] - The company plans to continue evaluating asset sales to enhance liquidity and optimize its balance sheet [7] Management's Comments on Operating Environment and Future Outlook - Management sees opportunities to improve cash flow in 2026, supported by improving net operating income across all segments [7] - The company anticipates lower interest expenses due to a potentially more favorable rate environment and plans to refinance the hotel following renovations [9] - Management expressed confidence in the strategic plan and the positive trends in operating performance across the portfolio [4] Other Important Information - The company is redeeming approximately 2 million shares of Series A preferred stock, which is expected to improve annual funds from operations by approximately $16 million [5] - The company has completed renovations at the Sheraton Grand Sacramento, which is expected to significantly impact profitability in 2026 [19] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

LifeMD (NasdaqGM:LFMD) Q4 2025 Earnings call March 09, 2026 04:30 PM ET Company ParticipantsDavid Larsen - Managing DirectorJustin Schreiber - CEOMarc Benathen - CFOConference Call ParticipantsEduardo Martinez-Montes - AnalystRyan Meyers - Senior Research AnalystSarah James - Equity Research AnalystSteve Dechert - Equity Research AnalystOperatorGood afternoon. Thank you for joining us today to discuss LifeMD's results for the fourth quarter and full year ended December 31st, 2025. Joining the call today are ...

Financial Data and Key Metrics Changes - LifeMD reported a revenue growth of 25% year-over-year for 2025, totaling $194.1 million, with a gross margin of 85.7%, a slight decrease of 50 basis points compared to the previous year [22][23] - The fourth quarter revenue grew 4% year-over-year to $46.9 million, with a gross margin of 87.1%, an expansion of 570 basis points from the prior year [20][21] - GAAP net income for the fourth quarter was $19 million or $0.41 per share, including a one-time benefit from the sale of WorkSimpli, while the adjusted EBITDA for the fourth quarter was $4.8 million, up from $1.1 million in the previous year [21][24] Business Line Data and Key Metrics Changes - The weight management business is experiencing record patient acquisition, with new signups approaching 700 per day, and customer acquisition costs have declined sequentially [4][19] - The men's health segment, represented by the Rex MD brand, has approximately 215,000 active patients and returned to growth in the second half of 2025 [8][19] - Women's health is a significant focus, with investments in launching this offering, including the acquisition of Optimal Human Health MD and partnerships with recognized experts in the field [5][6] Market Data and Key Metrics Changes - LifeMD has over 322,000 active subscribers and is onboarding approximately 1,200 new patients daily, reflecting strong brand demand [3][19] - The company expects to cover over 220 million lives through expanded partnerships with third-party benefits partners by the end of Q2 2026 [15][16] Company Strategy and Development Direction - LifeMD is focused on leveraging artificial intelligence to enhance care delivery, diagnostics, and patient operations, with plans to launch an AI clinical decision support tool in the first half of 2026 [11][12] - The company aims to build a comprehensive virtual healthcare platform that integrates emerging AI capabilities and insurance benefits, enhancing patient experience and operational efficiency [16][17] - LifeMD is committed to expanding its pharmacy operations, which are now licensed in all 50 states, to support personalized compounded medications and improve margins [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth trajectory, citing record demand in weight management and a diversifying specialty care platform [18] - The company anticipates returning to adjusted EBITDA profitability in Q2 2026, with revenue guidance for 2026 projected between $220 million and $230 million [25] Other Important Information - LifeMD's balance sheet is strong, with nearly $37 million in cash and no debt, allowing for aggressive investment in growth initiatives [3][24] - The company is seeing significant pipeline opportunities with large pharmaceutical companies, enhancing its attractiveness as a partner in the healthcare space [5] Q&A Session Summary Question: Demand for Wegovy pill and brand products - Management noted strong demand for the Wegovy pill since its launch in January, with nearly doubled new patient acquisition in the weight loss business [29] Question: Revenue model for Wegovy pill - The Wegovy pill is typically priced at $249 per month, with healthy gross margins around $100 per order [31] Question: Investments in Q1 2026 - The company plans to increase sales and marketing expenditures significantly, expecting to drive patient acquisition and revenue growth [34] Question: Drivers of revenue increase in 2026 - Growth will primarily come from subscriber count increases in the GLP-1 weight management business, women's health, and the Rex MD brand [37] Question: Women's health performance compared to other markets - Early performance in women's health shows higher intent and promising retention rates, with significant investments made in marketing and brand development [44][46] Question: Stickiness of Wegovy pill versus injectable - Initial retention rates for the Wegovy pill are better than the injectable, but long-term retention remains to be seen [54] Question: Comparison with competitors like Amazon - LifeMD differentiates itself through its own provider group and a comprehensive care platform, offering synchronous care and a range of specialty services [56][58]

Financial Data and Key Metrics Changes - The company reported full-year revenue of $40.9 million, representing a 26% growth over 2024 [5][21] - Fourth quarter revenue was $11.4 million, the highest revenue quarter of the year, up 13% from the third quarter but down slightly year-over-year [14][19] - Gross margin for the fourth quarter was 68.6%, down from 71.4% a year ago, but up from 63.8% in the third quarter [19] - Operating loss for the fourth quarter was $2.8 million, compared to an operating loss of about $200,000 in the prior year quarter [20] Business Line Data and Key Metrics Changes - The U.S. Orthotics and Prosthetics (O&P) channel achieved quarterly revenue exceeding $1 million for the first time, up 81% year-over-year [6][18] - Revenue from the O&P channel was up 81% for the quarter and doubled for the year [6][8] - The MyoConnect program contributed to 42% of fourth quarter revenue, up from 26% in the fourth quarter of 2024 [8] Market Data and Key Metrics Changes - International operations delivered quarterly revenues exceeding $2 million for the first time, growing 46% for the quarter and 48% for the year [8][18] - The company signed in-network contracts with additional Medicare Advantage and commercial payers, including a significant agreement with Elevance Health covering 45 million lives [10] Company Strategy and Development Direction - The company aims to grow revenue through direct-to-patient marketing and expand orders from recurring sources [4] - A focus on managing cost structure and enhancing manufacturing processes to demonstrate operating leverage as the company scales [4] - Continued innovation in product development to maintain market leadership, including the launch of the MyoPro 2X and development of MyoPro 3 [12][27] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth in recurring patient sources and the MyoConnect program, which is expected to reduce customer acquisition costs [8][28] - The company anticipates a revenue range of $43 million to $46 million for 2026, with a focus on stroke patients and recurring sources [24][25] - Management acknowledged challenges with Medicare Advantage payers but is encouraged by new payer contracts leading to more authorizations [17][41] Other Important Information - The company plans to activate the Myomo mobile app for patients and clinicians, which is expected to reduce costs associated with shipping laptops [12] - Cash burn was reported at $1.5 million in the fourth quarter, with operating cash flow negative at $1.1 million [22] Q&A Session Summary Question: What drove the increase in cost per pipeline ad in the MyoConnect program? - Management noted that the fourth quarter typically has higher advertising costs due to competition and has implemented changes to reduce costs moving forward [34][35] Question: Can you provide details on the O&P channel's performance? - The O&P channel had over $1 million in revenue with approximately 36 units ordered in the fourth quarter [39] Question: What are the assumptions for the U.S. O&P business in 2026 guidance? - Growth is expected in the O&P channel and international markets, while direct billing is anticipated to remain flat [40][41] Question: What is the current status of the pipeline and dropout rates? - The pipeline added 676 patients, slightly lower than previous quarters, with a dropout rate around 20% due to challenges with Medicare Advantage authorizations [45][56] Question: What is the expected gross margin for the upcoming quarters? - Management expects first quarter gross margin to be lower than the fourth quarter but aims to improve gross margin to the 70% range by the end of 2026 [59][61]

Financial Data and Key Metrics Changes - In Q4 2025, total consolidated revenue was $61.8 million, a 31% increase compared to Q3 2025 [5][6] - Media margin reached $19.1 million, up 49% from Q3 2025 [5][6] - Adjusted EBITDA was $0.2 million, an increase of $3.6 million from Q3 2025, representing 0.3% of Q4 revenue [6][20] - Full year 2025 revenue totaled $208.8 million, reflecting an 18% decline versus 2024 [7] - Adjusted EBITDA loss for the full year was $9 million, representing -4.3% of revenue [7][20] Business Line Data and Key Metrics Changes - Commerce Media Solutions contributed 56% of total Q4 revenue, more than doubling from 26% in Q4 2024 [5][7] - Q4 2025 revenue from Commerce Media Solutions was $34.7 million, representing 101% growth compared to Q4 2024 [16] - For the full year, Commerce Media Solutions revenue totaled $82.3 million, a 99% increase over 2024 [7][17] Market Data and Key Metrics Changes - The U.S. commerce media market is projected to grow at a compounded average growth rate of 21% from 2023 to 2027, reaching a total market value of $100 billion by 2027 [9] - As of year-end 2025, Commerce Media Solutions is operating at an annual run rate of $105 million [9] Company Strategy and Development Direction - The company has pivoted towards the high-growth commerce media industry, leveraging its owned and operated marketplaces [4] - The focus is on maintaining a profitable contribution from owned and operated businesses while investing in commerce media strategic adjacencies [10][11] - The company aims to establish leadership credentials in the commerce media segment and expand its geographical presence [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving strong double-digit year-over-year growth throughout 2026 [6][25] - The company anticipates a return to year-over-year revenue growth, ending a multi-year period of managed top-line decline [25] - Management highlighted the importance of maintaining financial flexibility and liquidity to support growth in Commerce Media Solutions [24] Other Important Information - The company raised over $19 million in equity capital during 2025 to support growth initiatives [23] - A new financing agreement was established, improving financial flexibility [23] Q&A Session Summary Question: Can you talk about the AI-based functionality in your Rebuy partnership? - Management indicated that AI has been embedded in their solutions for a long time, driving better performance through proprietary first-party data [31][32] Question: Can you elaborate on the convergence between owned and operated and Commerce Media capabilities? - Management noted that the legacy business has valuable data that enhances their ability to drive unique audience sets across different media partners [35][36] Question: What are your expectations for 2026 regarding Commerce Media growth? - Management expects strong double-digit growth for Commerce Media, despite an early contract termination impacting projections [40][41] Question: How is the macro environment affecting advertiser acquisition? - Management reported no significant pushback on pricing from advertisers and noted that return on ad spend has remained stable [43][44] Question: What is the outlook for gross margins moving forward? - Management anticipates gross margins to expand into the mid-20s% by the latter half of 2026 [54] Question: How do you view the competitive landscape in the commerce media space? - Management acknowledged limited competition from larger players and emphasized their direct engagement with advertisers as a competitive advantage [56][57]

Coherus Oncology (NasdaqGM:CHRS) Q4 2025 Earnings call March 09, 2026 04:30 PM ET Speaker6Good day, and thank you for standing by. Welcome to the Q4 and full year 2025 Coherus Oncology, Inc. earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during this session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised ...